✦ LIBER ✦

Reversed MUC1/EMA polarity in both mucinous and micropapillary breast carcinoma—reply

✍ Scribed by Barbashina, Violetta; Corben, Adriana D.; Akram, Muzaffar; Vallejo, Christina; Tan, Lee K.

Book ID: 122284463
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 45 KB
Volume: 45
Category: Article
ISSN: 1532-8392
DOI: 10.1016/j.humpath.2013.08.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reversed MUC1/EMA polarity in both mucin

Reversed MUC1/EMA polarity in both mucinous and micropapillary breast carcinoma

✍ Troxell, Megan L. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Aberrant expression of muc1 mucin in duc

Aberrant expression of muc1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast

✍ Ellen C.M. Mommers; Angelique M. Leonhart; Silvia von Mensdorff-Pouilly; Dick J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 91 KB 👁 2 views

MUC1 mucin is a high molecular weight transmembrane glycoprotein expressed on the apical cell surface of normal glandular epithelia. In many human adenocarcinomas, this protein is up-regulated and/or underglycosylated, and its expression changes from apical to the entire cell membrane. It is thought

The expression pattern of MUC1 (EMA) is

The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome in ‘pure’ ductal carcinoma in situ of the breast

✍ M A J De Roos; B Van Der Vegt; J L Peterse; C Patriarca; J De Vries; G H De Bock 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

Distinct sub-populations of carcinoma-as

Distinct sub-populations of carcinoma-associated MUC1 mucins as detected by the monoclonal antibody 9H8 and antibodies against the sialyl-Lewis a and sialyl-Lewis x epitopes in the circulation of breast-cancer patients

✍ Rein Sikut; Ke Zhang; Dan Baeckström; Gunnar C. Hansson 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 856 KB

The cancer-associated epitope defined by the monoclonal antibody (MAb) 9H8 was shown to be closely related to the T antigen (Thornsen-Friedenreich antigen) by its sensitivity to 0-glycanase treatment of a mucin glycopeptide known to express this epitope. The reactivity with this glycopeptide increas